We are live on
!
Find out more
SR
Summer Road Portfolio holdings
AUM
$142M
1-Year Est. Return
43.61%
This Fund
S&P 500
This Quarter
Est. Return
-2.09%
1 Year Est. Return
+43.61%
3 Year Est. Return
+101.14%
5 Year Est. Return
-35.41%
10 Year Est. Return
+349.33%
AUM
$31.6M
AUM Growth
-$673K
(-2.1%)
Cap. Flow
$0
Cap. Flow
% of AUM
0%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
1
New
–
Increased
–
Reduced
–
Closed
–
Top Buys
No buys this quarter
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Ocular Therapeutix
OCUL
$1.96B
| $31.6M | 100% |
6,122,089
| – | – |
|
Similar funds
EC
TA
AC
ACP
PC
YEPX
ALM
BRIA
Summer Road's Q2 2023 Portfolio in Review
As of Q2 2023, Summer Road held 1 position worth $31.6M, down 2.1% from $32.3M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Trading was light in Q2 2023: portfolio turnover was 0%. Summer Road opened no new positions and made no exits, leaving the 1-position portfolio largely intact.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.
- Summer Road's ten largest holdings make up 100% of its $31.6M portfolio in Q2 2023.
- Summer Road opened 0 new positions and closed 0 in Q2 2023.
- Summer Road's portfolio value fell 2.1% quarter-over-quarter to $31.6M.
Based on Summer Road's 13F filing for Q2 2023, filed 14 Aug 2023.